Review of prevalence of Simian Virus 40 (SV40) genomic infection in healthy subjects

Valentina Paracchini, Seymour Garte, Paola Pedotti, Emanuela Taioli

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Because of the carcinogenicity of SV40 in rodents, and its possible distribution through the polio vaccine, many studies have been conducted to determine if there is an association between SV40 genomic infection and different types of cancer; sometimes, these studies included data on the prevalence of genomic infection in healthy subjects as secondary information. We reviewed all the studies that reported the prevalence of SV40 genomic infection in healthy subjects, tested by PCR based methods. The 20 articles considered here included 1103 samples from healthy subjects, with a prevalence of infection ranging from 0 to 25.6%, with high heterogeneity, and no association with the type of sample analyzed (Mantel-Haenszel OR: 0.74; 95% CI: 0.44-1.23). The wide variation in frequency pose problems in terms of study design; in fact, the representativeness of the samples used as controls in the published studies may be very limited. Larger studies on healthy subjects, tested for SV40 genomic infection at various genomic regions, conducted in different geographic areas, are needed.

Original languageEnglish
Pages (from-to)77-83
Number of pages7
JournalMutation Research - Reviews in Mutation Research
Volume612
Issue number2
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Simian virus 40
Healthy Volunteers
Infection
Poliomyelitis
Rodentia
Vaccines
Cross-Sectional Studies
Polymerase Chain Reaction
Neoplasms

Keywords

  • Control populations
  • Epidemiology
  • Poliovirus infection

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis

Cite this

Review of prevalence of Simian Virus 40 (SV40) genomic infection in healthy subjects. / Paracchini, Valentina; Garte, Seymour; Pedotti, Paola; Taioli, Emanuela.

In: Mutation Research - Reviews in Mutation Research, Vol. 612, No. 2, 03.2006, p. 77-83.

Research output: Contribution to journalArticle

Paracchini, Valentina ; Garte, Seymour ; Pedotti, Paola ; Taioli, Emanuela. / Review of prevalence of Simian Virus 40 (SV40) genomic infection in healthy subjects. In: Mutation Research - Reviews in Mutation Research. 2006 ; Vol. 612, No. 2. pp. 77-83.
@article{6bc928ac6e3c4a63bf20231eed527bfb,
title = "Review of prevalence of Simian Virus 40 (SV40) genomic infection in healthy subjects",
abstract = "Because of the carcinogenicity of SV40 in rodents, and its possible distribution through the polio vaccine, many studies have been conducted to determine if there is an association between SV40 genomic infection and different types of cancer; sometimes, these studies included data on the prevalence of genomic infection in healthy subjects as secondary information. We reviewed all the studies that reported the prevalence of SV40 genomic infection in healthy subjects, tested by PCR based methods. The 20 articles considered here included 1103 samples from healthy subjects, with a prevalence of infection ranging from 0 to 25.6{\%}, with high heterogeneity, and no association with the type of sample analyzed (Mantel-Haenszel OR: 0.74; 95{\%} CI: 0.44-1.23). The wide variation in frequency pose problems in terms of study design; in fact, the representativeness of the samples used as controls in the published studies may be very limited. Larger studies on healthy subjects, tested for SV40 genomic infection at various genomic regions, conducted in different geographic areas, are needed.",
keywords = "Control populations, Epidemiology, Poliovirus infection",
author = "Valentina Paracchini and Seymour Garte and Paola Pedotti and Emanuela Taioli",
year = "2006",
month = "3",
doi = "10.1016/j.mrrev.2005.06.001",
language = "English",
volume = "612",
pages = "77--83",
journal = "Mutation Research - Reviews in Mutation Research",
issn = "1383-5742",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Review of prevalence of Simian Virus 40 (SV40) genomic infection in healthy subjects

AU - Paracchini, Valentina

AU - Garte, Seymour

AU - Pedotti, Paola

AU - Taioli, Emanuela

PY - 2006/3

Y1 - 2006/3

N2 - Because of the carcinogenicity of SV40 in rodents, and its possible distribution through the polio vaccine, many studies have been conducted to determine if there is an association between SV40 genomic infection and different types of cancer; sometimes, these studies included data on the prevalence of genomic infection in healthy subjects as secondary information. We reviewed all the studies that reported the prevalence of SV40 genomic infection in healthy subjects, tested by PCR based methods. The 20 articles considered here included 1103 samples from healthy subjects, with a prevalence of infection ranging from 0 to 25.6%, with high heterogeneity, and no association with the type of sample analyzed (Mantel-Haenszel OR: 0.74; 95% CI: 0.44-1.23). The wide variation in frequency pose problems in terms of study design; in fact, the representativeness of the samples used as controls in the published studies may be very limited. Larger studies on healthy subjects, tested for SV40 genomic infection at various genomic regions, conducted in different geographic areas, are needed.

AB - Because of the carcinogenicity of SV40 in rodents, and its possible distribution through the polio vaccine, many studies have been conducted to determine if there is an association between SV40 genomic infection and different types of cancer; sometimes, these studies included data on the prevalence of genomic infection in healthy subjects as secondary information. We reviewed all the studies that reported the prevalence of SV40 genomic infection in healthy subjects, tested by PCR based methods. The 20 articles considered here included 1103 samples from healthy subjects, with a prevalence of infection ranging from 0 to 25.6%, with high heterogeneity, and no association with the type of sample analyzed (Mantel-Haenszel OR: 0.74; 95% CI: 0.44-1.23). The wide variation in frequency pose problems in terms of study design; in fact, the representativeness of the samples used as controls in the published studies may be very limited. Larger studies on healthy subjects, tested for SV40 genomic infection at various genomic regions, conducted in different geographic areas, are needed.

KW - Control populations

KW - Epidemiology

KW - Poliovirus infection

UR - http://www.scopus.com/inward/record.url?scp=32344444282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32344444282&partnerID=8YFLogxK

U2 - 10.1016/j.mrrev.2005.06.001

DO - 10.1016/j.mrrev.2005.06.001

M3 - Article

C2 - 16081314

AN - SCOPUS:32344444282

VL - 612

SP - 77

EP - 83

JO - Mutation Research - Reviews in Mutation Research

JF - Mutation Research - Reviews in Mutation Research

SN - 1383-5742

IS - 2

ER -